Is 6M TCZ treatment enough to induce lasting remission in PMR? ➡️cohort of pts in SEMAPHORE trial ➡️among pts in remission after 6M TCZ, 1/4 were relapse-free after TCZ discontinuation ⏩6M treatment not enough to withdraw TCZ Ab1698 #ACR24 @RheumNow https://t.co/wTRTfX1fWq

• https://x.com/DrMiniDey/status/1858224335619768581/photo/1

Is #IL1 inhibition for 4 months a winner in #GCA —NOPE Anakinra daily 100mg sc 4/12 Underpowered but equal relapses and d/c #steroids not different #relapses esp after d/c #anakinra N=30 d/c due to #COVIDpandemic #1699 #ACR24 @RheumNow @ACRheum https://t.co/1TgloS5x8O

• https://x.com/Janetbirdope/status/1858224593452113923/photo/1

#Gout attack is assoc w 1.5 X MI, MACE in next 30 days @ACRheum @RheumNow #ACR24 https://t.co/7IeFbW6xW8

• https://twitter.com/nellziade/status/1858212544118222855

#HRT is not much of a risk of Breast cancer Compared to A drink a day of #ETOH #ACR24 @RheumNow @ACRheum https://t.co/LFgqbFocpb

• https://twitter.com/rheum2improve/status/1858215861510652040

A#1693 Change in FVC @ W12 or 24 has progn value @ w52 in AI-ILD Study SENSCIS (SSc) & INBUILD (SARD) trial PBO gps SENSCIS: OR for ILD progression 1.9 @ w12, 2.5 @ w24 INBUILD: OR 2.2 @ w12 & w24 Early PFTs predict outcomes @ 1 yr, short trials may be feasible #ACR24 @RheumNow https://t.co/8cICAeG0nr

• https://x.com/ericdeinmd/status/1858226507136503942/photo/1
• https://x.com/ericdeinmd/status/1858226507136503942/photo/1

How do you manage skin in Sscl? -RNA pol III + high risk for skin progression. -Limited+ low risk + stable Sscl no need for immunesuppresors. -Look for EF in pts with generalized morphea. -Ttnt of skin depending on other organ involvements. -If no Raynaud’s/hands spared think of… https://t.co/HBjO5eQfjT https://t.co/oS1ZmkanGA

• https://x.com/i/web/status/1858226808392474817
• https://x.com/AdelaCastro222/status/1858226808392474817/photo/1
• https://x.com/AdelaCastro222/status/1858226808392474817/photo/1
• https://x.com/AdelaCastro222/status/1858226808392474817/photo/1
• https://x.com/AdelaCastro222/status/1858226808392474817/photo/1

de Boysson et al. RCT anakinra in GCA. 30 patients. Week 52 relapse 53% in anakinra vs 46% in placebo. @RheumNow #ACR24 Abstr#1699 https://t.co/sqDWUlkXAX

• https://x.com/RichardPAConway/status/1858227355447378085/photo/1

Sarilumab is better than #MTX in #PMR Reminder #RCT of #MTX in #PMR was a NEGATIVE #trial #1697 60 % #sarilumab in #RWE could d/c #Prednisone after failure of initial #pred #Rx >1yr pred prior vs 40% MTX Comparative effectiveness sari v MTX #1700 #ACR24 @ACRheum @RheumNow https://t.co/4YXIBz0OK7

• https://x.com/Janetbirdope/status/1858228695531393051/photo/1
• https://x.com/Janetbirdope/status/1858228695531393051/photo/1

RheumNow’s expanded coverage of #ACR24 is sponsored in part by Novartis. All content is chosen by RheumNow & its faculty.

A retrospective analysis by Dr. ERayens et al showed that RA pts >/=50y given 2 RZV doses were less likely to develop HZ vs. unvaxxed grp Incidence of PHN was also lower in the vaccinated group (0.2py vs.1.9py) RZV is effective in preventing HZ & PhN @Rheumnow #ACR25 abs0977 https://t.co/JhYBYnLmhl

• https://x.com/RHEUMarampa/status/1858219577865331006/photo/1

2023 @ACRheum guidance recommends #MediterraneanDiet in RA What are barriers/facilitators to following the diet? Many pts are willing to try but don't follow it Barriers➡️ food insecurity & aversions Many are unaware Do you talk to your pts about diet? Ab1673 #ACR24 @RheumNow

Bolhuis et al. PMR MODE study. MTX 25mg/week in recently diagnosed PMR. 52 weeks. 56 patients. Nada, zip, no effect. GC free remission 67% vs 68%. No difference in any secondary outcome. @RheumNow #ACR24 Abstr#1697 #ACRbest https://t.co/Mb909u1zFT https://t.co/dShyBF4WST

• Results of a One Year Randomized Double-Blind Placebo-Controlled Trial with Met…
• https://x.com/RichardPAConway/status/1858220056968126725/photo/1

RA-ILD: 💡Lifetime prevalence seems low but ~40% can have subclincal. 💡Screen early in symptomatic pts. 💡RA disease control decreases ILD progression and mortality. 💡RA-ILD UIP pattern seems to respond to immunosuppression. #ACR24 @RheumNow https://t.co/q3iACMeYVU

• https://x.com/AdelaCastro222/status/1858220498351751197/photo/1
• https://x.com/AdelaCastro222/status/1858220498351751197/photo/1
• https://x.com/AdelaCastro222/status/1858220498351751197/photo/1

When you stop 🛑 #TCZ #tocilizumab at 6 months of #Rx in #PMR RELAPSES are V high DON’T stop #Toci in PMR too Early Rapid and frequent flares #ACR24 @RheumNow @ACRheum #1698 https://t.co/IX5EJOcIY5

• https://x.com/Janetbirdope/status/1858221372205617199/photo/1